We are excited to share that our Head of Biostatistics, Prof. Krassimir Kalinov, has recently contributed as an author to several new publications, including:
• COVID-19 Infection in Chronic Kidney Disease Patients: Risk Factors for Death and Acute Kidney Injury – https://pubmed.ncbi.nlm.nih.gov/36294815/
• Serum and Urinary Biomarkers in COVID-19 Patients with or without Baseline Chronic Kidney Disease – https://pubmed.ncbi.nlm.nih.gov/36983566/
• Renin-angiotensin-aldosterone system blockers in COVID-19 patients with or without chronic kidney disease – https://pubmed.ncbi.nlm.nih.gov/36482641/
• Assessment of extrafine beclomethasone/formoterol for the treatment of chronic obstructive pulmonary disease: A non-interventional study in a Bulgarian population – https://pubmed.ncbi.nlm.nih.gov/36252915/
We are confident that Prof. Kalinov’s contributions will further enhance the scientific community’s understanding of different diseases and the application of Biostatistics in real-world settings.
As an organization committed to science, Comac Medical continues to support scientific activities through our daily activities and not only.
Constant Contribution to Science
April 4, 2023
Share:
News
Selecting the most appropriate clinical trial design is of utmost importance, and it can be the difference between...
[Sofia, Bulgaria] – Comac Medical proudly welcomes Brian Swindley as our new Global Head of Project Management. Brian...
This May, Comac Medical proudly celebrates the 20th anniversary of our North Macedonia office. Originally established with headquarters...